Prashant Gahtori
Overview
Explore the profile of Prashant Gahtori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sati A, Kyllait P, Gahtori P, Bhat H, Hussain M, Gupta G, et al.
J Complement Integr Med
. 2025 Feb;
PMID: 39957105
Objectives: To evaluate the antidepressant-like effects of Phenylthiazolyl-1,3,5-triazine derivatives through behavioral tests, molecular docking, and histopathological analysis in a rat brain model of depression. Methods: Phenylthiazolyl-1,3,5-triazine derivatives were synthesized and...
2.
Ipe R, Oh J, Kumar S, Ahmad I, Nath L, Bindra S, et al.
Mol Divers
. 2024 Aug;
PMID: 39145880
Eighteen compounds derived from two sub-series, (HC1-HC9) and (HF1-HF9), were synthesized and evaluated for their inhibitory activities against monoamine oxidase (MAO). HC (chalcone) series showed higher inhibitory activity against MAO-B...
3.
Singh P, Sinha S, Gahtori P, Tivari S, Srivastava V
Org Biomol Chem
. 2024 Mar;
22(13):2523-2538.
PMID: 38456306
The decatungstate anion (WO) appears to exhibit especially interesting properties as a photocatalyst. Because of its unique photocatalytic properties, it is now recognised as a promising tool in organic chemistry....
4.
Ipe R, Kumar S, Benny F, Jayan J, Manoharan A, Sudevan S, et al.
Pharmaceuticals (Basel)
. 2023 Sep;
16(9).
PMID: 37765118
Monoamine oxidases (MAOs) are a family of flavin adenine dinucleotide-dependent enzymes that catalyze the oxidative deamination of a wide range of endogenous and exogenous amines. Multiple neurological conditions, including Parkinson's...
5.
Manoharan A, Oh J, Benny F, Kumar S, Abdelgawad M, Ghoneim M, et al.
Molecules
. 2023 Aug;
28(16).
PMID: 37630420
Monoamine oxidase (MAO, EC 1.4.3.4) is responsible for the oxidative breakdown of both endogenous and exogenous amines and exists in MAO-A and MAO-B isomers. Eighteen indole-based phenylallylidene derivatives were synthesized...
6.
7.
Pande A, Manchanda M, Bhat H, Bairy P, Kumar N, Gahtori P
J Biomol Struct Dyn
. 2021 Apr;
40(18):8286-8300.
PMID: 33829956
A phytoalexin, Resveratrol remains a legendary anticancer drug candidate in the archives of scientific literature. Although earlier wet-lab experiments rendering its multiple biological targets, for example, epidermal growth factors, Pro-apoptotic...
8.
Kumar V, Sachan R, Rahman M, Rub R, Patel D, Sharma K, et al.
Biomed Pharmacother
. 2021 Mar;
137:111298.
PMID: 33761590
The objective of this study was to evaluate the anticancer effects of Melstoma malabathricum L. (MM) MDA-MB-231 human breast cancer and in vivo mammary tumor model and decipher the potential...
9.
Gogoi P, Shakya A, Ghosh S, Gogoi N, Gahtori P, Singh N, et al.
J Biochem Mol Toxicol
. 2020 Dec;
35(3):e22682.
PMID: 33332673
Malaria continues to become a major global health problem, particularly in Sub-Saharan Africa, Asia, and Latin America. The widespread emergence of resistance to first-line drugs has further bolstered an urgent...
10.
Kumar V, Rahman M, Gahtori P, Al-Abbasi F, Anwar F, Kim H
Expert Opin Drug Deliv
. 2020 Dec;
18(6):673-694.
PMID: 33295218
Introduction: Hepatocellular carcinoma (HCC) is a major health problem worldwide. Conventional therapies covering either chemotherapy or combination therapy still have sub-optimal responses with significant adverse effects and toxicity. Moreover, tumor...